Ligand validation:6HJX

LMT: DODECYL-BETA-D-MALTOSIDE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6HJX_LMT_A_503	27%	45%	0.182	0.845	1.19	0.95	5	1	0	0	91%	1
6HJX_LMT_B_401	20%	45%	0.239	0.844	1.13	1	5	2	0	0	100%	1
6HJX_LMT_C_401	16%	44%	0.242	0.831	1.16	1.01	5	2	1	0	91%	1
6HJX_LMT_E_401	15%	44%	0.305	0.881	1.16	1.01	5	2	0	0	91%	1
6HJX_LMT_D_401	6%	43%	0.338	0.793	1.15	1.07	5	2	0	0	91%	1
6HK0_LMT_G_401	29%	33%	0.155	0.871	1.38	1.27	4	5	2	0	69%	1
5NV9_LMT_A_504	99%	31%	0.045	0.983	0.57	2.12	-	12	1	0	100%	1
3CAY_LMT_A_512	99%	59%	0.04	0.975	0.66	0.9	-	1	0	0	100%	1
7M78_LMT_L_202	95%	44%	0.073	0.976	1.13	1.04	3	2	0	0	100%	1
3T2Y_LMT_A_501	83%	30%	0.085	0.943	1.26	1.54	3	10	2	0	100%	1
4U8Y_LMT_C_1101	83%	64%	0.096	0.953	0.43	0.92	-	1	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.